Anzeige
Mehr »
Mittwoch, 16.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
AM

WKN: A14WL9 | ISIN: FR0011051598 | Ticker-Symbol: A1H
Stuttgart
16.09.26 | 09:14
0,493 Euro
-2,18 % -0,011
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
AMOEBA Chart 1 Jahr
5-Tage-Chart
AMOEBA 5-Tage-Chart
RealtimeGeldBriefZeit
0,4940,49609:42

Aktuelle News zur AMOEBA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAmoeba: Syngenta und Amoéba schließen exklusiven europäischen Vertriebsvertrag, um Getreideerzeugern ein wegweisendes Biofungizid bereitzustellen570Basel, Schweiz, und Chassieu, Frankreich, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Die exklusive Vereinbarung umfasst den Getreidemarkt in der Europäischen Union, im Vereinigten Königreich, in der Ukraine...
► Artikel lesen
08.09.AMOEBA: Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers531The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first market launches from 2028/29; This new-generation biocontrol...
► Artikel lesen
23.07.AMOEBA: Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides753Chassieu (France), 23 July 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, and its partner Koppert, world...
► Artikel lesen
30.06.AMOEBA: Amoéba has received marketing authorization in France for its biofungicide AXPERA756Chassieu (France), 30 June 2026 - 07:30 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...
► Artikel lesen
AMOEBA Aktie jetzt für 0€ handeln
08.06.AMOEBA: Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew751Chassieu (France), 8 June 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...
► Artikel lesen
06.05.AMOEBA: Two new exceptional trial permits in the Netherlands in 2026 for Amoéba's biocontrol solution1.224Amoéba and Koppert have each been granted special authorization to use AXPERA technology on a wide range of crops These exemptions include food crops for consumption. Chassieu (France), 6...
► Artikel lesen
28.04.AMOEBA: Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards705Chassieu (France), 28 April 2026 - 6:00 p.m. - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has received...
► Artikel lesen
13.04.AMOEBA: Amoéba and Koppert highlight the potential of AXPERA technology in Brazil for strategic crops600Chassieu (France), 13 April 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
26.03.AMOEBA: Amoéba announces the success of its capital increase and raises EUR 6.67 million1.451Chassieu (France), 26 March 2026 - 8:00 a.m. - Amoéba (FR0011051598 - ALMIB ), an industrial greentech specialized in the development of natural microbiological solutions based on the patented...
► Artikel lesen
25.03.AMOEBA: Amoéba strengthens its financial visibility to support its industrial and commercial expansion1.645Press release This press release must not be released, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press...
► Artikel lesen
19.03.Amoeba - Preparing for commercialisation in 2026826Amoéba's FY25 was marked by regulatory and pre-commercial progress across biocontrol and cosmetics, alongside higher industrial deployment spend ahead of a planned move into commercialisation in 2026....
► Artikel lesen
19.03.AMOEBA: Amoéba: Ordinary and Extraordinary General Meeting of 3 April 2026746Chassieu (France), 19 March 2026 - 8:45 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
18.03.AMOEBA: Amoéba announces the publication of its Universal Registration Document 2025592Chassieu (France), 18 March 2026 - 6 p.m. - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialized in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
11.03.AMOEBA: Amoéba receives its first order from Koppert and confirms its transformation into a commercial company763Press release Chassieu (France), 11 March 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based...
► Artikel lesen
23.02.AMOEBA: Amoéba: final phase for marketing authorisation of AXPERA712The ANSES evaluation process for the application submitted in March 2025 is currently in its final stage. At the same time, French and Italian agricultural sectors have begun procedures to obtain...
► Artikel lesen
23.02.AMOEBA: 2025 annual results: major regulatory and commercial advances paving the way for commercialisation in 2026699Chassieu (France), 23 February 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
20.01.AMOEBA: Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution783Chassieu (France), 20 January 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
18.12.25AMOEBA: AXPERA wins the SIVAL d'Or Award: further recognising of the effectiveness of Amoéba's biocontrol solution802Official award ceremony: Wednesday, 14 January 2026, starting at 7 p.m. Innovation Area of the Grand Palais exhibition centre Angers Exhibition Centre (France) Chassieu (France), 18 December 2025...
► Artikel lesen
18.11.25AMOEBA: A natural breakthrough in protecting cereals and field crops // Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK729Media Release Basel, Switzerland and Chassieu, France, 11/18/2025 Amoebas. These single-celled microorganisms are now at the heart of one of agriculture's latest biological innovation...
► Artikel lesen
29.10.25AMOEBA: Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use622Chassieu (France), 29 October 2025 - 08:00 am - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialized in the development of natural microbiological solutions based on the patented...
► Artikel lesen
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1